Sarcoma  >>  mocetinostat (MGCD0103)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
mocetinostat (MGCD0103) / Otsuka, BMS
NCT02303262: SARC018: A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma

Completed
2
20
US
Mocetinostat, Gemcitabine
Sarcoma Alliance for Research through Collaboration
Metastatic Leiomyosarcoma
12/16
12/16

Download Options